Literature DB >> 20016968

Circulating miRNA and cancer diagnosis.

Yi Tie1, BinDong Liu, HanJiang Fu, XiaoFei Zheng.   

Abstract

miRNAs are a class of small RNA molecules with regulatory function, and play an important role in tumor development and progression. It has been demonstrated that tumor-derived miRNAs exist in the circulating nucleic acids of cancer patients. This phenomenon implies that detection of the circulating miRNA may be an effective method for non-invasive diagnosis of cancer. In this review, we summarize the applications of the circulating miRNA as biomarkers in cancer diagnosis, as well as the latest research progress in this area.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20016968     DOI： 10.1007/s11427-009-0158-5

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN： 1006-9305


  14 in total

1.  Discrimination of gastric cancer from normal by serum RNA based on surface-enhanced Raman spectroscopy (SERS) and multivariate analysis.

Authors:  Yanping Chen; Gang Chen; Xiongwei Zheng; Cheng He; Shangyuan Feng; Yan Chen; Xiaoqian Lin; Rong Chen; Haisan Zeng
Journal:  Med Phys       Date:  2012-09       Impact factor: 4.071

Review 2.  MicroRNA-21 gene and cancer.

Authors:  Yong Huang; You Bing Yang; Xiao Hui Zhang; Xue Li Yu; Zhan Bin Wang; Xiang Chao Cheng
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

Review 3.  Extracellular microRNA: a new source of biomarkers.

Authors:  Alton Etheridge; Inyoul Lee; Leroy Hood; David Galas; Kai Wang
Journal:  Mutat Res       Date:  2011-03-23       Impact factor: 2.433

4.  Circulating miRNA as novel markers for diastolic dysfunction.

Authors:  Nandini Nair; Sandeep Kumar; Enrique Gongora; Sudhiranjan Gupta
Journal:  Mol Cell Biochem       Date:  2012-12-18       Impact factor: 3.396

5.  Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.

Authors:  Junbo Xia; Man Luo; Lujun Dai; Liusheng Wang; Limin Wang; Jing Zhu
Journal:  J Clin Lab Anal       Date:  2021-03-08       Impact factor: 2.352

6.  Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.

Authors:  Risheng Que; Guoping Ding; Jionghuang Chen; Liping Cao
Journal:  World J Surg Oncol       Date:  2013-09-04       Impact factor: 2.754

7.  MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma.

Authors:  Yanyang Liu; Zhixi Li; Lu Wu; Zi Wang; Xia Wang; Yang Yu; Qian Zhao; Feng Luo
Journal:  Cancer Cell Int       Date:  2014-03-07       Impact factor: 5.722

Review 8.  The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer.

Authors:  Xin Qin; Haisheng Xu; Wenrong Gong; Wenbin Deng
Journal:  Front Oncol       Date:  2015-01-05       Impact factor: 6.244

9.  Associations between genetic variants located in mature microRNAs and risk of lung cancer.

Authors:  Dengrui Li; Guiyun Zhu; Hongqin Di; Hui Li; Xinyan Liu; Min Zhao; Zhihua Zhang; Yonghui Yang
Journal:  Oncotarget       Date:  2016-07-05

10.  Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.

Authors:  Valeriy Poroyko; Tamara Mirzapoiazova; Arin Nam; Isa Mambetsariev; Bolot Mambetsariev; Xiwei Wu; Aliya Husain; Everett E Vokes; Deric L Wheeler; Ravi Salgia
Journal:  Oncotarget       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.